[Real-world outcomes of glaucoma surgical procedures for open-angle glaucoma].
Real-world-Ergebnisse von glaukomchirurgischen Verfahren beim Offenwinkelglaukom.
Adverse events
Effectiveness
Glaucoma surgery
Glaucoma treatment
Safety
Journal
Die Ophthalmologie
ISSN: 2731-7218
Titre abrégé: Ophthalmologie
Pays: Germany
ID NLM: 9918402288106676
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
accepted:
18
09
2023
medline:
6
11
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
ppublish
Résumé
This article provides an overview of real-world outcomes in glaucoma surgical procedures. While randomized clinical trials provide valuable insights, they do not fully reflect real-world clinical practice. Real-world studies enable the evaluation of outcomes in uncontrolled settings and play a crucial role in counselling and decision-making for glaucoma treatment. By examining real-world data the article aims to identify rare adverse events that may go unnoticed in controlled clinical trials. The focus is on assessing the effectiveness and safety of glaucoma surgical procedures beyond the controlled trial setting. Diese Arbeit bietet einen Überblick über Real-world-Ergebnisse bei glaukomchirurgischen Verfahren. Obwohl randomisierte klinische Studien wichtige Erkenntnisse liefern, spiegeln sie nicht das reale Versorgungsgeschehen wider. Real-world-Studien ermöglichen eine Beurteilung der Ergebnisse außerhalb kontrollierter Settings und sind für die Beratung und Entscheidungsfindung bei Glaukombehandlung von großer Bedeutung. Durch die Untersuchung von Real-world-Daten zielt die Arbeit darauf ab, seltene unerwünschte Ereignisse zu identifizieren, die in kontrollierten klinischen Studien möglicherweise übersehen werden. Der Fokus liegt darauf, die Wirksamkeit und Sicherheit von glaukomchirurgischen Verfahren über das kontrollierte Studiensetting hinaus zu bewerten.
Autres résumés
Type: Publisher
(ger)
Diese Arbeit bietet einen Überblick über Real-world-Ergebnisse bei glaukomchirurgischen Verfahren. Obwohl randomisierte klinische Studien wichtige Erkenntnisse liefern, spiegeln sie nicht das reale Versorgungsgeschehen wider. Real-world-Studien ermöglichen eine Beurteilung der Ergebnisse außerhalb kontrollierter Settings und sind für die Beratung und Entscheidungsfindung bei Glaukombehandlung von großer Bedeutung. Durch die Untersuchung von Real-world-Daten zielt die Arbeit darauf ab, seltene unerwünschte Ereignisse zu identifizieren, die in kontrollierten klinischen Studien möglicherweise übersehen werden. Der Fokus liegt darauf, die Wirksamkeit und Sicherheit von glaukomchirurgischen Verfahren über das kontrollierte Studiensetting hinaus zu bewerten.
Identifiants
pubmed: 37880486
doi: 10.1007/s00347-023-01941-2
pii: 10.1007/s00347-023-01941-2
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
1107-1116Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol 99:220–226
pubmed: 25193672
Wolfram C, Schuster AK (2022) Glaucoma care in Germany-results of a survey among German ophthalmologists-part 2: treatment. Ophthalmologie 119:1140–1148
pubmed: 35925336
Saheb H, Ahmed IIK (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104
pubmed: 22249233
Jordan JF, Wecker T, van Oterendorp C, Anton A, Reinhard T, Boehringer D et al (2013) Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 251:2753–2760
pubmed: 24158374
pmcid: 3889259
Akil H, Chopra V, Huang A, Loewen N, Noguchi J, Francis BA (2016) Clinical results of ab interno trabeculotomy using the Trabectome in patients with pigmentary glaucoma compared to primary open angle glaucoma. Clin Experiment Ophthalmol 44:563–569
pubmed: 26946187
Ting JLM, Damji KF, Stiles MC, Trabectome Study Group (2012) Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg 38:315–323
pubmed: 22322166
Strzalkowska A, Strzalkowski P, Al Yousef Y, Grehn F, Hillenkamp J, Loewen NA (2021) Exact matching of trabectome-mediated ab interno trabeculectomy to conventional trabeculectomy with mitomycin C followed for 2 years. Graefes Arch Clin Exp Ophthalmol 259:963–970
pubmed: 33263824
Jea SY, Francis BA, Vakili G, Filippopoulos T, Rhee DJ (2012) Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma. Ophthalmology 119:36–42
pubmed: 21982416
Kornmann HL, Fellman RL, Feuer WJ, Butler MR, Godfrey DG, Smith OU et al (2019) Early results of goniotomy with the Kahook dual blade, a novel device for the treatment of glaucoma. Clin Ophthalmol 13:2369–2376
pubmed: 31819362
pmcid: 6896929
Sieck EG, Epstein RS, Kennedy JB, SooHoo JR, Pantcheva MB, Patnaik JL et al (2018) Outcomes of Kahook dual blade Goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma 1:75–81
pubmed: 32672636
Shue A, Levine RM, Gallousis GM, Teng CC (2019) Cyclodialysis cleft associated with Kahook dual blade goniotomy. J Curr Glaucoma Pract 13:74–76
pubmed: 31564797
pmcid: 6743314
Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A (2019) Intermediate results of iStent or iStent inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther 8:87–100
pubmed: 30721523
pmcid: 6393257
Klamann MKJ, Gonnermann J, Pahlitzsch M, Maier A‑KB, Joussen AM, Torun N et al (2015) iStent inject in phakic open angle glaucoma. Graefes Arch Clin Exp Ophthalmol 253:941–947
pubmed: 25912085
Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C et al (2021) Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of Cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol 139:983–989
pubmed: 34264292
Grierson I, Saheb H, Kahook MY, Johnstone MA, Ahmed IIK, Schieber AT et al (2015) A novel Schlemm’s canal scaffold: histologic observations. J Glaucoma 24:460–468
pubmed: 24240886
Jabłońska J, Lewczuk K, Rękas MT (2023) Comparison of safety and efficacy of Hydrus and iStent combined with phacoemulsyfication in open angle glaucoma patients: 24-month follow-up. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph20054152
doi: 10.3390/ijerph20054152
pubmed: 36981780
pmcid: 10048898
Salimi A, Kassem R, Santhakumaran S, Harasymowycz P (2023) Three-year outcomes of a Schlemm canal microstent (Hydrus Microstent) with concomitant phacoemulsification in open-angle glaucoma. Ophthalmol Glaucoma 6:137–146
pubmed: 36038108
Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, Larrosa JM, Fea A, Lemij H et al (2015) A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology 122:1283–1293
pubmed: 25972254
Loayza-Gamboa W, Martel-Ramirez V, Inga-Condezo V, Valderrama-Albino V, Alvarado-Villacorta R, Valera-Cornejo D (2020) Outcomes of combined prolene gonioscopy assisted transluminal trabeculotomy with phacoemulsification in open-angle glaucoma. Clin Ophthalmol 14:3009–3016
pubmed: 33061287
pmcid: 7537843
Cubuk MO, Ucgul AY, Unsal E (2020) Gonioscopy-assisted transluminal trabeculotomy as an option after failed trabeculectomy. Int Ophthalmol 40:1923–1930
pubmed: 32279221
Sharkawi E, Lindegger DJ, Artes PH, Lehmann-Clarke L, El Wardani M, Misteli M et al (2021) Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up. Br J Ophthalmol 105:977–982
pubmed: 32727734
Guo C‑Y, Qi X‑H, Qi J‑M (2020) Systematic review and Meta-analysis of treating open angle glaucoma with gonioscopy-assisted transluminal trabeculotomy. Int J Ophthalmol 13:317–324
pubmed: 32090043
pmcid: 7013777
Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh Y‑J, Nangia RS et al (2017) Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 183:25–36
pubmed: 28784554
Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I et al (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257:983–996
pubmed: 30758653
Mansouri K, Bravetti GE, Gillmann K, Rao HL, Ch’ng TW, Mermoud A (2019) Two-year outcomes of XEN gel Stent surgery in patients with open-angle glaucoma. Ophthalmol Glaucoma 2:309–318
pubmed: 32672673
Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K (2021) Combined and stand-alone XEN 45 gel stent implantation: 3‑year outcomes and success predictors. Acta Ophthalmol 99:e531–e539
pubmed: 32930515
Lenzhofer M, Kersten-Gomez I, Sheybani A, Gulamhusein H, Strohmaier C, Hohensinn M et al (2019) Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clinical Exper Ophthalmology. https://doi.org/10.1111/ceo.13463
doi: 10.1111/ceo.13463
Rauchegger T, Angermann R, Willeit P, Schmid E, Teuchner B (2021) Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Acta Ophthalmol 99:369–375
pubmed: 32996702
Sng CC, Wang J, Hau S, Htoon HM, Barton K (2018) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Experiment Ophthalmol 46:339–345
pubmed: 29053204
Bormann C, Schmidt M, Busch C, Rehak M, Scharenberg CT, Unterlauft JD (2022) Implantation of XEN after failed trabeculectomy: an efficient therapy? Klin Monbl Augenheilkd 239:86–93
pubmed: 34571551
Buffault J, Graber M, Bensmail D, Bluwol É, Jeanteur M‑N, Abitbol O et al (2020) Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep 10:4527
pubmed: 32161332
pmcid: 7066242
Gupta C, Mathews D (2019) XEN® stent complications: a case series. BMC Ophthalmol 19:253
pubmed: 31830935
pmcid: 6909486
Karri B, Gupta C, Mathews D (2018) Endophthalmitis following XEN stent exposure. J Glaucoma 27:931–933
pubmed: 29952822
Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD (2020) Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep 10:19337
pubmed: 33168873
pmcid: 7653954
Cappelli F, Cutolo CA, Olivari S, Testa V, Sindaco D, Pizzorno C et al (2022) Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: a 3-year retrospective analysis. BMJ Open Ophthalmol 7:e830
pubmed: 35047670
pmcid: 8728414
Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK et al (2021) Ab-externo microshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology 128:1710–1721
pubmed: 34051211
Pawiroredjo SSM, Bramer WM, Pawiroredjo ND, Pals J, Poelman HJ, de Vries VA et al (2022) Efficacy of the PRESERFLO microshunt and a meta-analysis of the literature. J Clin Med Res. https://doi.org/10.3390/jcm11237149
doi: 10.3390/jcm11237149
Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M et al (2022) Effectiveness of microshunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma 5:210–218
pubmed: 34478904
Quaranta L, Micheletti E, Carassa R, Bruttini C, Fausto R, Katsanos A et al (2021) Efficacy and safety of PreserFlo® microshunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study. Adv Ther 38:4403–4412
pubmed: 34251652
pmcid: 8342380
Micheletti E, Riva I, Bruttini C, Quaranta L (2020) A case of delayed-onset hemorrhagic choroidal detachment after PreserFlo Microshunt implantation in a glaucoma patient under anticoagulant therapy. J Glaucoma 29:e87–e90
pubmed: 32568812
Brambati M, Bettin P, Ramoni A, Battista M, Bandello F (2022) A case of endophthalmitis following needling procedure after PRESERFLO® Micro Shunt implantation. Eur J Ophthalmol 32:NP83–NP86
pubmed: 34015943
Jamke M, Herber R, Haase MA, Jasper CS (2023) PRESERFLO
doi: 10.1007/s00417-023-06075-4
pubmed: 37133501
pmcid: 10155172
Wagner FM, Schuster AK, Munder A, Muehl M, Chronopoulos P, Pfeiffer N et al (2022) Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy. Acta Ophthalmol 100:e1120–e1126
pubmed: 34626093
Kuet M‑L, Azuara-Blanco A, Barton K, King AJ (2022) Will the PRESERFLO
doi: 10.1038/s41433-022-02326-6
pubmed: 36477732
pmcid: 9735154
Stingl JV, Wagner FM, Liebezeit S, Baumgartner R, Spät H, Schuster AK et al (2023) Long-term efficacy and safety of modified canaloplasty versus trabeculectomy in open-angle glaucoma. Life. https://doi.org/10.3390/life13020516
doi: 10.3390/life13020516
pubmed: 36836873
pmcid: 9963969
Nassri L, Plange N, Lindemann F, Schellhase H, Walter P, Kuerten D (2020) Therapieerfolg von Kanaloplastik und Trabekulektomie durch denselben Operateur mit demselben Erfahrungslevel im Langzeitverlauf. Ophthalmologe 117:1025–1032
pubmed: 31996998
Grieshaber MC, Pienaar A, Olivier J, Stegmann R (2010) Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol 94:1478–1482
pubmed: 20962352
Seuthe A‑M, Ivanescu C, Leers S, Boden K, Januschowski K, Szurman P (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results. Arbeitsphysiologie 254:1591–1597
Gesser C, Wiermann A, Keserü M, Richard G, Klemm M (2014) Long-term follow-up after deep sclerectomy. Klin Monbl Augenheilkd 231:535–539
pubmed: 24715409
Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A (2004) Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 30:1225–1231
pubmed: 15177596
Schuster AK, Uhrig M, Pfeiffer N, Hoffmann EM (2022) Wie lernt man eine Trabekulektomie operieren? Die Ophthalmol 119:1006–1016
Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119:694–702
pubmed: 22196977
Wagner FM, Schuster AK, Kianusch K, Stingl J, Pfeiffer N, Hoffmann EM (2023) Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. BMJ Open 13:e68403
pubmed: 36737088
pmcid: 9900049
Chen PP (2003) Blindness in patients with treated open-angle glaucoma. Ophthalmology 110:726–733
pubmed: 12689894
Singh J, O’Brien C, Chawla HB (1995) Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye 9(Pt 4):460–466
pubmed: 7498567
Edmunds B, Thompson JR, Salmon JF, Wormald RP (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16:297–303
pubmed: 12032721
Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111
pubmed: 12698052
Montesano G, Ometto G, King A, Garway-Heath DF, Crabb DP (2023) Two-year visual field outcomes of the treatment of advanced glaucoma study (TAGS). Am J Ophthalmol 246:42–50
pubmed: 36228777
Weber C, Hundertmark S, Brinken R, Holz FG, Mercieca K (2022) Erste klinische Ergebnisse mit dem PAUL®-Glaukom-Implantat an der Universitäts-Augenklinik Bonn. Ophthalmologie 119:1267–1274
pubmed: 35925340
Goulet RJ 3rd, A‑DT P, Cantor LB, WuDunn D (2008) Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115:1141–1147
pubmed: 18164068
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2009) Three-year-follow-up of the tube versus Trabeculectomy study. Am J Ophthalmol 148(5):670–684
pubmed: 19674729
Godinho G, Barbosa-Breda J, Oliveira-Ferreira C, Madeira C, Melo A, Falcão-Reis F et al (2021) Anterior chamber versus ciliary Sulcus Ahmed glaucoma valve tube placement: longitudinal evaluation of corneal endothelial cell profiles. J Glaucoma 30:170–174
pubmed: 33955946
Iwasaki K, Arimura S, Takihara Y, Takamura Y, Inatani M (2018) Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE 13:e201342
pubmed: 30048529
pmcid: 6062117
José P, Barão RC, Teixeira FJ, Marques RE, Peschiera R, Barata A et al (2022) One-year efficacy and safety of the PAUL glaucoma implant using a standardized surgical protocol. J Glaucoma 31:201–205
pubmed: 34930872
Tan MCJ, Choy HYC, Koh Teck CV, Aquino MC, Sng CCA, Lim DKA et al (2022) Two-year outcomes of the Paul glaucoma implant for treatment of glaucoma. J Glaucoma 31:449–455
pubmed: 35180153
pmcid: 9148669
Wang S, Gao X, Qian N (2016) The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis. BMC Ophthalmol 16:83
pubmed: 27277579
pmcid: 4898360
Hoffmann EM, Hengerer F, Klabe K, Schargus M, Thieme H, Voykov B (2021) Glaucoma surgery today. Ophthalmologe 118:239–247
pubmed: 32632493
Samuelson TW, Sarkisian SR Jr, Lubeck DM, Stiles MC, Duh Y‑J, Romo EA et al (2019) Prospective, randomized, controlled pivotal trial of an Ab Interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology 126:811–821
pubmed: 30880108